Malignant Melanoma Recruiting Phase 2 Trials for Pexidartinib (DB12978)

Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS / Melanoma / Melanoma malignant

IndicationStatusPhase
DBCOND0029825 (Malignant Melanoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02071940PLX3397 KIT in Acral aNd mucOsal MelanomaTreatment